NorthCoast Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$5.47M Buy
43,636
+11,933
+38% +$1.54M 0.2% 101
2021
Q2
$3.94M Sell
31,703
-109,661
-78% -$13.8M 0.14% 124
2021
Q1
$16.7M Sell
141,364
-11,855
-8% -$1.39M 0.68% 45
2020
Q4
$18M Sell
153,219
-11,109
-7% -$1.22M 0.81% 37
2020
Q3
$17.1M Sell
164,328
-22,782
-12% -$2.29M 0.87% 37
2020
Q2
$17.2M Sell
187,110
-359
-0.2% -$34.4K 0.98% 32
2020
Q1
$16.9M Buy
+187,469
New +$19.9M 1.08% 32
2019
Q3
Sell
-12,642
Closed -$1.23M 257
2019
Q2
$1.23M Buy
+12,642
New +$1.15M 0.08% 138
2014
Q2
Sell
-18,302
Closed -$1.13M 182
2014
Q1
$1.13M Hold
18,302
0.07% 103
2013
Q4
$1.05M Hold
18,302
0.07% 113
2013
Q3
$975K Buy
+18,302
New +$985K 0.07% 105

Other funds holding MDT

NorthCoast Asset Management's MDT Position: Q3 2021 in Review

NorthCoast Asset Management increased its Medtronic (MDT) stake by 38% in Q3 2021, buying an estimated $1.54M and bringing the position to 43,636 shares worth $5.47M. The position accounts for 0.2% of the portfolio, ranked #101.

NorthCoast Asset Management first reported a position in MDT in Q3 2013 and has held it in 11 quarters since. The position peaked at $18M in Q4 2020. 2,024 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • NorthCoast Asset Management held 43,636 shares of Medtronic worth $5.47M as of Q3 2021.
  • NorthCoast Asset Management bought 11,933 Medtronic shares in Q3 2021, an estimated $1.54M.
  • Medtronic made up 0.2% of NorthCoast Asset Management's portfolio in Q3 2021, its #101 holding.
  • NorthCoast Asset Management first reported a position in Medtronic in Q3 2013 and has held it in 11 quarters since.
  • NorthCoast Asset Management's Medtronic position peaked at $18M in Q4 2020.
  • 2,024 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.